Product Name | NebuSelect™ Recombinant Human B7-H6/NCR3LG1, His-tag |
---|---|
Catalog Number | NBL-241050 |
Alias/Synonyms | B7-H6/NCR3LG1; B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6 |
Appearance | see COA |
Molecule Weight | Asp25-Ser262 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q68D85-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-241050-100ug | 100ug | Inquire | Inquire | |
NBL-241050-1mg | 1mg | Inquire | Inquire | |
NBL-241050-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human B7-H6/NCR3LG1, His-tag
Catalog#:
NBL-241050
Description:
NebuSelect™ Recombinant Human B7-H6/NCR3LG1, His-tag(Cat#NBL-241050) is expressed in HEK293 with His tag at the C-Terminus.It contains Asp25-Ser262.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 27.8 kDa. Due to glycosylation, the protein migrates to 50-68 kDa based on Bis-Tris PAGE result.
Target Name:
B7-H6/NCR3LG1; B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6
Target Information:
B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Amino Acid Sequence:
Asp25-Ser262
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.